or PO(OR<7>)2, or ii) n is 2 then Y is CH("EWG")2, or b) a terminal olefin substituted with i) an aryl or heteroaryl, ii) hydroxyl and a C1-C6 alkyl, phenyl or (CH2)m-CO2R<6> where m is 1 to 3, or c) C3-C6 cycloalkyl (optionally substituted with a halogen, (PO(OC2H5)2)2 or CN); R<3> is hydrogen or C1-C6 alkyl; R<4> is hydrogen, hydroxyl, C1-C6 alkyl, alkoxy, benzyloxy or phenoxy; R<5> is hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, phenoxy, C1-C6 alkylthio, thiophenyl, NH2, aryl (except that R<5> is other than phenyl when R<4> and Y are both hydrogen) or heteroaryl; R<6> is H, C1-C6 alkyl, benzyl, phenyl, phenyl substituted with one to five F, C1, Br, I, NO2, OCH3 or C1-C4 alkyl; and R<7> is H, C1-C6 alkyl, benzyl, phenyl, phenyl substituted with one to five F, C1, Br, I, NO2, OCH3 or C1-C4 alkyl, or where both R<7>'s are taken together to form a CH2-CH2, CH2-CH2-CH2 or CH2-C(CH3)2-CH2 whereby a heterocyclic ring containing the bonded P atom and the two O atoms is formed. The compounds are useful as anti-inflammatory and antiarthritic agents.">
会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~